csrxp_admin, Author at CSRxP - Page 9 of 90

CSRxP LAUNCHES SIX-FIGURE ADVERTISING CAMPAIGN TO HOLD BIG PHARMA ACCOUNTABLE FOR ANTICOMPETITIVE PRACTICES AND EGREGIOUS DRUG PRICING

Campaign Spoofs Big Pharma’s Direct-to-Consumer (DTC) Ads While Highlighting… Read More

DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE EXTENDING MONOPOLIES, KEEPING PRICES HIGH ON GLP-1S

Novo Nordisk Alone Has Filed 320 Patents on Single Active Ingredient Behind… Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Big Pharma Giant Johnson & Johnson Reports Earnings That Beating Wall… Read More

CSRxP STATEMENT ON U.S. SENATE AND U.S. HOUSE REINTRODUCTION OF Q1/Q2 REFORMS TO FOSTER GREATER COMPETITION, LOWER DRUG PRICES

Lawmakers Should Advance Bipartisan Solution to Crack Down on Anti-Competitive… Read More

THEY SAID IT! SENATE JUDICIARY CALLS OUT BIG PHARMA’S ANTI-COMPETITIVE PRACTICES THAT KEEP PRESCRIPTION DRUG PRICES HIGH

Senators on Both Sides of the Aisle Highlight Concerns with Big Pharma’s… Read More

CSRxP STATEMENT ON SENATE JUDICIARY PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE, LOWER DRUG PRICES

Committee Markup Advances Legislation to Crack Down on Big Pharma’s… Read More

BIG PHARMA WATCH: PFIZER AVOIDED PAYING BILLIONS IN U.S. TAXES THROUGH “EGREGIOUS TAX GIMMICK”

Big Pharma Giant Used “Round-Tripping” Tax Avoidance Scheme to Attribute… Read More

FACT SHEET: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS, TAXPAYERS AND THE U.S. HEALTH CARE SYSTEM BILLIONS OF DOLLARS

BIG PHARMA’S PATENT ABUSE IS THE ROOT CAUSE OF OUT-OF-CONTROL PRESCRIPTION… Read More

CSRxP ANALYSIS FINDS BIG PHARMA’S DIRECT-TO-CONSUMER (DTC) ADVERTISING COSTS U.S. TAXPAYERS BILLIONS OF DOLLARS

Study Finds Reducing or Taxing Brand Name Drug Companies’ Nearly $14 Billion… Read More

CSRxP APPLAUDS U.S. SENATE REINTRODUCTION OF BIPARTISAN, MARKET-BASED SOLUTIONS TO LOWER DRUG PRICES BY ADDRESSING BIG PHARMA’S PATENT ABUSE

Cracking Down on Anti-Competitive Tactics Like Patent-Thicketing and… Read More

They Said It!: Lawmakers And FDA Nominee Highlight Greater Competition As Critical To Lowering Prescription Drug Prices

U.S. Senate Confirmation Hearing Called Attention to Big Pharma’s Egregious… Read More

ICYMI: CSRxP SURVEY FINDS AMERICAN VOTERS OVERWHELMINGLY HOLD BIG PHARMA RESPONSIBLE FOR HIGH DRUG PRICES

Across Political Spectrum, Fabrizio Ward Finds Voters Identify Pharmaceutical… Read More